235 related articles for article (PubMed ID: 32898275)
1. What Determines Cognitive Functioning in the Oldest-Old? The EMIF-AD 90+ Study.
Legdeur N; Badissi M; Yaqub M; Beker N; Sudre CH; Ten Kate M; Gordon MF; Novak G; Barkhof F; van Berckel BNM; Holstege H; Muller M; Scheltens P; Maier AB; Visser PJ
J Gerontol B Psychol Sci Soc Sci; 2021 Sep; 76(8):1499-1511. PubMed ID: 32898275
[TBL] [Abstract][Full Text] [Related]
2. White Matter Hyperintensities and Hippocampal Atrophy in Relation to Cognition: The 90+ Study.
Legdeur N; Visser PJ; Woodworth DC; Muller M; Fletcher E; Maillard P; Scheltens P; DeCarli C; Kawas CH; Corrada MM
J Am Geriatr Soc; 2019 Sep; 67(9):1827-1834. PubMed ID: 31169919
[TBL] [Abstract][Full Text] [Related]
3. Vascular burden and cognition: Mediating roles of neurodegeneration and amyloid PET.
Ottoy J; Ozzoude M; Zukotynski K; Adamo S; Scott C; Gaudet V; Ramirez J; Swardfager W; Cogo-Moreira H; Lam B; Bhan A; Mojiri P; Kang MS; Rabin JS; Kiss A; Strother S; Bocti C; Borrie M; Chertkow H; Frayne R; Hsiung R; Laforce RJ; Noseworthy MD; Prato FS; Sahlas DJ; Smith EE; Kuo PH; Sossi V; Thiel A; Soucy JP; Tardif JC; Black SE; Goubran M;
Alzheimers Dement; 2023 Apr; 19(4):1503-1517. PubMed ID: 36047604
[TBL] [Abstract][Full Text] [Related]
4. Amyloid-β, cortical thickness, and subsequent cognitive decline in cognitively normal oldest-old.
Pelkmans W; Legdeur N; Ten Kate M; Barkhof F; Yaqub MM; Holstege H; van Berckel BNM; Scheltens P; van der Flier WM; Visser PJ; Tijms BM
Ann Clin Transl Neurol; 2021 Feb; 8(2):348-358. PubMed ID: 33421355
[TBL] [Abstract][Full Text] [Related]
5. Resilience to cognitive impairment in the oldest-old: design of the EMIF-AD 90+ study.
Legdeur N; Badissi M; Carter SF; de Crom S; van de Kreeke A; Vreeswijk R; Trappenburg MC; Oudega ML; Koek HL; van Campen JP; Keijsers CJPW; Amadi C; Hinz R; Gordon MF; Novak G; Podhorna J; Serné E; Verbraak F; Yaqub M; Hillebrand A; Griffa A; Pendleton N; Kramer SE; Teunissen CE; Lammertsma A; Barkhof F; van Berckel BNM; Scheltens P; Muller M; Maier AB; Herholz K; Visser PJ
BMC Geriatr; 2018 Nov; 18(1):289. PubMed ID: 30477432
[TBL] [Abstract][Full Text] [Related]
6. White matter hyperintensities and amyloid are independently associated with entorhinal cortex volume among individuals with mild cognitive impairment.
Guzman VA; Carmichael OT; Schwarz C; Tosto G; Zimmerman ME; Brickman AM;
Alzheimers Dement; 2013 Oct; 9(5 Suppl):S124-31. PubMed ID: 23375566
[TBL] [Abstract][Full Text] [Related]
7. Hippocampal subregional volume changes in elders classified using positron emission tomography-based Alzheimer's biomarkers of β-amyloid deposition and neurodegeneration.
Busatto Filho G; Duran FLS; Squarzoni P; Coutinho AMN; Rosa PGP; Torralbo L; Pachi CGDF; da Costa NA; Porto FHG; Carvalho CL; Brucki SMD; Nitrini R; Forlenza OV; Leite CDC; Buchpiguel CA; de Paula Faria D
J Neurosci Res; 2021 Feb; 99(2):481-501. PubMed ID: 33073383
[TBL] [Abstract][Full Text] [Related]
8. Effects of amyloid pathology and neurodegeneration on cognitive change in cognitively normal adults.
Bilgel M; An Y; Helphrey J; Elkins W; Gomez G; Wong DF; Davatzikos C; Ferrucci L; Resnick SM
Brain; 2018 Aug; 141(8):2475-2485. PubMed ID: 29901697
[TBL] [Abstract][Full Text] [Related]
9. White matter hyperintensity topography in Alzheimer's disease and links to cognition.
Garnier-Crussard A; Bougacha S; Wirth M; Dautricourt S; Sherif S; Landeau B; Gonneaud J; De Flores R; de la Sayette V; Vivien D; Krolak-Salmon P; Chételat G
Alzheimers Dement; 2022 Mar; 18(3):422-433. PubMed ID: 34322985
[TBL] [Abstract][Full Text] [Related]
10. Association of short-term cognitive decline and MCI-to-AD dementia conversion with CSF, MRI, amyloid- and
Ottoy J; Niemantsverdriet E; Verhaeghe J; De Roeck E; Struyfs H; Somers C; Wyffels L; Ceyssens S; Van Mossevelde S; Van den Bossche T; Van Broeckhoven C; Ribbens A; Bjerke M; Stroobants S; Engelborghs S; Staelens S
Neuroimage Clin; 2019; 22():101771. PubMed ID: 30927601
[TBL] [Abstract][Full Text] [Related]
11. Distinct spatial contributions of amyloid pathology and cerebral small vessel disease to hippocampal morphology.
Xhima K; Ottoy J; Gibson E; Zukotynski K; Scott C; Feliciano GJ; Adamo S; Kuo PH; Borrie MJ; Chertkow H; Frayne R; Laforce R; Noseworthy MD; Prato FS; Sahlas DJ; Smith EE; Sossi V; Thiel A; Soucy JP; Tardif JC; Goubran M; Black SE; Ramirez J;
Alzheimers Dement; 2024 May; 20(5):3687-3695. PubMed ID: 38574400
[TBL] [Abstract][Full Text] [Related]
12. Longitudinal Relationships of White Matter Hyperintensities and Alzheimer Disease Biomarkers Across the Adult Life Span.
Luo J; Ma Y; Agboola FJ; Grant E; Morris JC; McDade E; Fagan AM; Benzinger TLS; Hassenstab J; Bateman RJ; Perrin RJ; Gordon BA; Goyal M; Strain JF; Yakushev I; Day GS; Xiong C;
Neurology; 2023 Jul; 101(2):e164-e177. PubMed ID: 37202169
[TBL] [Abstract][Full Text] [Related]
13. Association between brain amyloid deposition and longitudinal changes of white matter hyperintensities.
Cha WJ; Yi D; Ahn H; Byun MS; Chang YY; Choi JM; Kim K; Choi H; Jung G; Kang KM; Sohn CH; Lee YS; Kim YK; Lee DY
Alzheimers Res Ther; 2024 Mar; 16(1):50. PubMed ID: 38454444
[TBL] [Abstract][Full Text] [Related]
14. White matter hyperintensities are associated with disproportionate progressive hippocampal atrophy.
Fiford CM; Manning EN; Bartlett JW; Cash DM; Malone IB; Ridgway GR; Lehmann M; Leung KK; Sudre CH; Ourselin S; Biessels GJ; Carmichael OT; Fox NC; Cardoso MJ; Barnes J;
Hippocampus; 2017 Mar; 27(3):249-262. PubMed ID: 27933676
[TBL] [Abstract][Full Text] [Related]
15. Association of vascular brain injury, neurodegeneration, amyloid, and cognitive trajectory.
Han JW; Maillard P; Harvey D; Fletcher E; Martinez O; Johnson DK; Olichney JM; Farias ST; Villeneuve S; Jagust W; Mungas D; DeCarli C
Neurology; 2020 Nov; 95(19):e2622-e2634. PubMed ID: 32732300
[TBL] [Abstract][Full Text] [Related]
16. Linking white matter hyperintensities to regional cortical thinning, amyloid deposition, and synaptic density loss in Alzheimer's disease.
Zhang J; Chen H; Wang J; Huang Q; Xu X; Wang W; Xu W; Guan Y; Liu J; Wardlaw JM; Deng Y; Xie F; Li B
Alzheimers Dement; 2024 Jun; 20(6):3931-3942. PubMed ID: 38648354
[TBL] [Abstract][Full Text] [Related]
17. Sex differences in the development of mild cognitive impairment and probable Alzheimer's disease as predicted by hippocampal volume or white matter hyperintensities.
Burke SL; Hu T; Fava NM; Li T; Rodriguez MJ; Schuldiner KL; Burgess A; Laird A
J Women Aging; 2019; 31(2):140-164. PubMed ID: 29319430
[TBL] [Abstract][Full Text] [Related]
18. White matter hyperintensity patterns: associations with comorbidities, amyloid, and cognition.
Bachmann D; von Rickenbach B; Buchmann A; Hüllner M; Zuber I; Studer S; Saake A; Rauen K; Gruber E; Nitsch RM; Hock C; Treyer V; Gietl A
Alzheimers Res Ther; 2024 Apr; 16(1):67. PubMed ID: 38561806
[TBL] [Abstract][Full Text] [Related]
19. The Brain Chart of Aging: Machine-learning analytics reveals links between brain aging, white matter disease, amyloid burden, and cognition in the iSTAGING consortium of 10,216 harmonized MR scans.
Habes M; Pomponio R; Shou H; Doshi J; Mamourian E; Erus G; Nasrallah I; Launer LJ; Rashid T; Bilgel M; Fan Y; Toledo JB; Yaffe K; Sotiras A; Srinivasan D; Espeland M; Masters C; Maruff P; Fripp J; Völzk H; Johnson SC; Morris JC; Albert MS; Miller MI; Bryan RN; Grabe HJ; Resnick SM; Wolk DA; Davatzikos C;
Alzheimers Dement; 2021 Jan; 17(1):89-102. PubMed ID: 32920988
[TBL] [Abstract][Full Text] [Related]
20. Regional White Matter Hyperintensity Influences Grey Matter Atrophy in Mild Cognitive Impairment.
Vipin A; Foo HJL; Lim JKW; Chander RJ; Yong TT; Ng ASL; Hameed S; Ting SKS; Zhou J; Kandiah N
J Alzheimers Dis; 2018; 66(2):533-549. PubMed ID: 30320575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
